UK says home-grown cancer pill too costly to use

February 2, 2012 — LONDON (Reuters) - Britain's health cost watchdog NICE sparked a major row on Thursday by snubbing a pricey new prostate cancer pill discovered at the country's top cancer research center, a decision critics said was bad for patients and research.

CORRECTION: Seed therapy for prostate cancer may zap fertility

February 1, 2012 — NEW YORK (Reuters Health) - Radioactive "seeds" that are sometimes used to treat early prostate cancer may do widespread damage to the DNA in a man's sperm, a small study finds.

Seed therapy for prostate cancer may zap fertility

February 1, 2012 — NEW YORK (Reuters Health) - Radioactive "seeds" that are sometimes used to treat early prostate cancer may do widespread damage to the DNA in a man's sperm, a small study finds.

Crab-like robot built to remove stomach cancer

February 1, 2012 — SINGAPORE (Reuters) - Inspired by Singapore's famous chilli crab dish, researchers have created a miniature robot with a pincer and a hook that can remove early-stage stomach cancers without leaving any scars.

Breast cancer charity ends Planned Parenthood funding

February 1, 2012 — The Komen Foundation, best-known for the Race for the Cure fundraisers it sponsors around the country each year, did not immediately respond to a request for comment from Reuters.

Diabetes drugs tied to pancreatic cancer risk

January 31, 2012 — NEW YORK (Reuters Health) - A new study links the diabetes drug metformin to fewer cases of pancreatic cancer -- at least in women -- but finds other diabetes medications are associated with a higher risk of the disease.

U.S. FDA approves Roche skin cancer drug

January 30, 2012 —

Arsenic cancer risk still high decades later

January 24, 2012 — NEW YORK (Reuters Health) - People exposed to very high levels of arsenic in Chilean drinking water back in the 1950s and 60s are still showing a higher-than-normal risk of bladder cancer -- years after the arsenic problem was brought under control, a new study shows.

FDA approves BTG's drug for cancer toxicity

January 18, 2012 — WASHINGTON (Reuters) - U.S. health regulators gave the nod on Tuesday to a drug from British specialty drugmaker BTG Plc that helps cancer patients get rid of toxic levels of a chemotherapy treatment.

China cancer village tests law against pollution

January 16, 2012 — XIAOXIN, China (Reuters) - Nothing in Wu Wenyong's rural childhood hinted he would end up on a hospital bed aged 15, battling two kinds of cancer.

Cancer drug gets stronger label warning

January 13, 2012 —

CORRECTION: Gene expression profiles may improve cancer prognosis

January 9, 2012 — NEW YORK (Reuters Health) - Integrating genomic information with traditional clinical risk factors can refine the prognosis and help optimize treatment strategies for women with early breast cancer, a research team at Duke University reports in the Journal of the American Medical Association this week.

REFILE: Eighth retraction marks slide of lung cancer work

January 9, 2012 — NEW YORK (Reuters Health) - In a reminder of how much a once-heralded area of lung cancer research has crumbled, a former Duke oncologist and his colleagues issued their eighth study retraction late last week.

Argentina's Fernandez sent home, never had cancer

January 9, 2012 — BUENOS AIRES (Reuters) - Argentine President Cristina Fernandez never had cancer despite being diagnosed with the disease last month and having her thyroid gland removed on January 4, her spokesman said on Saturday.

PSA screening doesn't prevent cancer deaths: study

January 6, 2012 — NEW YORK (Reuters Health) - Annual screening for prostate cancer doesn't cut men's chances of dying from the disease, according to the latest results of a large screening trial.